Clinical challenges: Myeloma and concomitant Type 2 Diabetes

Clinical challenges: Myeloma and concomitant Type 2 Diabetes

Show other versions (1)

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wil...

Full description

Bibliographic Details
Main Authors: Yasar Albushra Abdul Rahiem Ahmed, Awad Eltayeb
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2013-03-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Diabetes mellitus
Multiple myeloma
Online Access:https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463

Similar Items

Similar Items